Page last updated: 2024-10-31

neostigmine and Cough

neostigmine has been researched along with Cough in 2 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Cough: A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Korkmaz, MO1
Sayhan, H1
Guven, M1
STUART, WD1

Trials

1 trial available for neostigmine and Cough

ArticleYear
Does sugammadex decrease the severity of agitation and complications in pediatric patients undergoing adenotonsillectomy?
    Saudi medical journal, 2019, Volume: 40, Issue:9

    Topics: Adenoidectomy; Adolescent; Anesthesia, General; Atropine; Child; Child, Preschool; Cough; Double-Bli

2019

Other Studies

1 other study available for neostigmine and Cough

ArticleYear
THE OTOLARYNGOLOGIC ASPECTS OF MYASTHENIA GRAVIS.
    The Laryngoscope, 1965, Volume: 75

    Topics: Child; Cough; Deglutition Disorders; Edrophonium; Geriatrics; Humans; Myasthenia Gravis; Neostigmine

1965